Production of TNFα and IL-6 by Activated Whole Blood from HIV-1 Infected Patients Detected by a One-Stage Procedure: Relationship with the Phenotype of HIV-1 Isolates
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using small volumes of WB (25μl) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine mea...
Saved in:
Published in | MICROBIOLOGY and IMMUNOLOGY Vol. 41; no. 12; pp. 939 - 946 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Blackwell Publishing Ltd
01.01.1997
Center For Academic Publications Japan Center for Academic Publications Japan |
Subjects | |
Online Access | Get full text |
ISSN | 0385-5600 1348-0421 |
DOI | 10.1111/j.1348-0421.1997.tb01953.x |
Cover
Loading…
Abstract | Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using small volumes of WB (25μl) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL-6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean+2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean -2 S.D. of the control group. Low IL-6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T-cell count in peripheral blood. Our data point out a disarray in TNFα and IL-6 production by WB from HIV-1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV-1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV-1 isolates isolated from patients. The one-stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV-1 positive individuals and predicting HIV-1 phenotype. |
---|---|
AbstractList | Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNF alpha and IL-6 production using small volumes of WB (25 mu l) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNF alpha and IL-6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNF alpha than the mean + 2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNF alpha values were lower than the mean - 2 S.D. of the control group. Low IL-6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNF alpha production in vitro and plasma level of TNF alpha . We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T-cell count in peripheral blood. Our data point out a disarray in TNF alpha and IL-6 production by WB from HIV-1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV-1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNF alpha produced by WB and the phenotype of HIV-1 isolates isolated from patients. The one-stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV-1 positive individuals and predicting HIV-1 phenotype. Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using small volumes of WB (25μl) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL-6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean+2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean -2 S.D. of the control group. Low IL-6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T-cell count in peripheral blood. Our data point out a disarray in TNFα and IL-6 production by WB from HIV-1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV-1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV-1 isolates isolated from patients. The one-stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV-1 positive individuals and predicting HIV-1 phenotype. Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using small volumes of WB (25 μl) from HIV‐1 positive patients with a one‐step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL‐6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean + 2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean −2 S.D. of the control group. Low IL‐6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T‐cell count in peripheral blood. Our data point out a disarray in TNFα and IL‐6 production by WB from HIV‐1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV‐1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV‐1 isolates isolated from patients. The one‐stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV‐1 positive individuals and predicting HIV‐1 phenotype. Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using small volumes of WB (25 μl) from HIV‐1 positive patients with a one‐step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL‐6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean + 2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean −2 S.D. of the control group. Low IL‐6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T‐cell count in peripheral blood. Our data point out a disarray in TNFα and IL‐6 production by WB from HIV‐1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV‐1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV‐1 isolates isolated from patients. The one‐stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV‐1 positive individuals and predicting HIV‐1 phenotype. |
Author | Bocket-Mouton, Laurence De Groote, Donat Wattré, Pierre Benyoucef, Samira Vilain, Virginie Hober, Didier Gérard, Yann Ajana, Faïza Lion, Georges Shen, Lu |
Author_xml | – sequence: 1 givenname: Samira surname: Benyoucef fullname: Benyoucef, Samira organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France – sequence: 2 givenname: Didier surname: Hober fullname: Hober, Didier organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France – sequence: 3 givenname: Lu surname: Shen fullname: Shen, Lu organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France – sequence: 4 givenname: Faïza surname: Ajana fullname: Ajana, Faïza organization: Service Régional des Maladies Infectieuses, Hôpital Dron, Tourcoing, France – sequence: 5 givenname: Donat surname: De Groote fullname: De Groote, Donat organization: Medgenix Diagnostics, S. A., Research and Development Department, Fleurus, Belgium – sequence: 6 givenname: Laurence surname: Bocket-Mouton fullname: Bocket-Mouton, Laurence organization: Service Régional des Maladies Infectieuses, Hôpital Dron, Tourcoing, France – sequence: 7 givenname: Yann surname: Gérard fullname: Gérard, Yann organization: Service Régional des Maladies Infectieuses, Hôpital Dron, Tourcoing, France – sequence: 8 givenname: Georges surname: Lion fullname: Lion, Georges organization: Centre Hospitalier, Valenciennes, France – sequence: 9 givenname: Virginie surname: Vilain fullname: Vilain, Virginie organization: Centre Hospitalier, Valenciennes, France – sequence: 10 givenname: Pierre surname: Wattré fullname: Wattré, Pierre organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France |
BackLink | https://cir.nii.ac.jp/crid/1570009753174902912$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2184755$$DView record in Pascal Francis |
BookMark | eNqVkt9u0zAUxiM0JLrBO1gIcZdix3Fi74ptZV3F_gkKk7ixXOeEuKR2iV3WPhHXvAjPhLNWBXG3XDiOz-98n-PPh8mBdRaS5CXBQxKfN_MhoTlPcZ6RIRGiHIYZJoLR4fpJMtiXDpIBppylrMD4WXLo_RzjrMx4Pkh-3nauWulgnEWuRtPr89-_kLIVmlymBZpt0Ems_VABKnTXuBbQaetcherOLdDF5HNK0MTWoPv6rQoGbPBoBGG7EtsVurGQfgzqK6BopaFadXCMPkCrek_fmCW6N6FBoYlAA9aFzRL6rezUvYsk-OfJ01q1Hl7s3kfJp_N307OL9PJmPDk7uUw1w4KmHHORz5iq2IwWmDBegcqyqihyoatc64yVhALwmc7iJydQVwCFqFnFAZOC06Pk9VZ32bnvK_BBLozX0LbKglt5SQpaEk568NUOVF6rtu6U1cbLZWcWqtvIjPC8ZCxix1tMd877Duo9QbDsI5Rz2eck-5xkH6HcRSjXsfntf83ahIdzC50y7aMk7k0Lm0eYy6vJ1cP0759aY-IG-pGwEmMsSkZJmQucCZJFbLzF5r5Pe2-lumB0C3IRb5UhoixlHr2y3Sio2BO6UZ0EG5XSrZLxAdb_CH2TRUlLJu-ux_KUi9H0CxvJ9_QPUoLs-A |
CODEN | MIIMDV |
CitedBy_id | crossref_primary_10_1073_pnas_0507577102 crossref_primary_10_1089_107999001753124426 crossref_primary_10_1016_S0753_3322_00_00018_4 |
Cites_doi | 10.4049/jimmunol.148.11.3505 10.1172/JCI115493 10.1111/j.1348-0421.1996.tb01083.x 10.1007/BF00915059 10.1007/BF00211217 10.1016/0090-1229(92)90069-Z 10.1126/science.2832945 10.1111/j.1348-0421.1993.tb01706.x 10.1016/0002-9343(88)90576-1 10.1016/S0140-6736(86)90169-8 10.4049/jimmunol.144.2.480 10.1126/science.3277274 10.1016/1043-4666(92)90062-V 10.1016/1043-4666(92)90021-I 10.1016/0022-1759(93)90130-Y 10.1097/00002030-199112000-00001 10.1016/0090-1229(90)90001-7 10.1016/0090-1229(89)90144-X 10.1111/j.1365-2249.1993.tb03349.x 10.1016/0022-1759(91)90188-L 10.4049/jimmunol.141.1.99 10.1016/S0140-6736(87)90826-9 10.1089/aid.1989.5.139 10.1089/aid.1991.7.381 10.1097/00126334-199212000-00010 |
ContentType | Journal Article |
Copyright | Center for Academic Publications Japan owned by Center for Academic Publications Japan (Publisher) 1998 INIST-CNRS |
Copyright_xml | – notice: Center for Academic Publications Japan – notice: owned by Center for Academic Publications Japan (Publisher) – notice: 1998 INIST-CNRS |
DBID | BSCLL RYH AAYXX CITATION IQODW 7T5 7U9 H94 |
DOI | 10.1111/j.1348-0421.1997.tb01953.x |
DatabaseName | Istex CiNii Complete CrossRef Pascal-Francis Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1348-0421 |
EndPage | 946 |
ExternalDocumentID | 2184755 10_1111_j_1348_0421_1997_tb01953_x MIM01953 130003484464 article_mandi1977_41_12_41_12_939_article_char_en ark_67375_WNG_B89DTZ5D_K |
Genre | article |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1OC 24P 29M 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5HH 5LA 5RE 5VS 7.U 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 A8Z AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACPOU ACPRK ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-E D-F DCZOG DIK DPXWK DRFUL DRSTM DU5 E3Z EBD EBS EJD EMB EMOBN ESTFP F00 F01 F04 F5P FEDTE G-S G.N GODZA H.T H.X HF~ HGLYW HVGLF HZ~ J0M JSF JSH KQ8 LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MM. MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OHT OIG OK1 OVD P2P P2W P2X P4D PQQKQ Q.N Q11 QB0 R.K RJT ROL RX1 RZJ SJN SUPJJ SV3 TEORI TKC TWZ UB1 V8K W8V W99 WBKPD WHG WIH WIK WIN WNSPC WOHZO WXSBR WYISQ X7M XG1 XOL XSB ZGI ZXP ZZTAW ~IA ~WT 1OB AAHQN AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ALVPJ OVT RYH AAYXX CITATION IQODW 7T5 7U9 H94 |
ID | FETCH-LOGICAL-c5093-80894b5ad5b360158dea22d6649cd4cc25713ee8bc2d4c81efdee69f5d8e01683 |
ISSN | 0385-5600 |
IngestDate | Sun Aug 24 04:04:11 EDT 2025 Mon Jul 21 09:16:24 EDT 2025 Thu Apr 24 23:12:00 EDT 2025 Tue Jul 01 02:26:02 EDT 2025 Wed Jan 22 16:40:58 EST 2025 Thu Jun 26 22:36:33 EDT 2025 Wed Sep 03 06:10:02 EDT 2025 Wed Oct 30 09:53:32 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Human Immunopathology HIV-1 virus Cytokine Retroviridae AIDS Immune deficiency Lentivirus Host virus relation Infection Virus Interleukin 6 Whole blood Phenotype Viral disease Human immunodeficiency virus Tumor necrosis factor α |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5093-80894b5ad5b360158dea22d6649cd4cc25713ee8bc2d4c81efdee69f5d8e01683 |
Notes | ark:/67375/WNG-B89DTZ5D-K istex:03CFB2A115FB4A6591E984DA85E6481DFC978A71 ArticleID:MIM01953 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/mandi1977/41/12/41_12_939/_article/-char/en |
PQID | 16371818 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_16371818 pascalfrancis_primary_2184755 crossref_primary_10_1111_j_1348_0421_1997_tb01953_x crossref_citationtrail_10_1111_j_1348_0421_1997_tb01953_x wiley_primary_10_1111_j_1348_0421_1997_tb01953_x_MIM01953 nii_cinii_1570009753174902912 jstage_primary_article_mandi1977_41_12_41_12_939_article_char_en istex_primary_ark_67375_WNG_B89DTZ5D_K |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1997-01-01 |
PublicationDateYYYYMMDD | 1997-01-01 |
PublicationDate_xml | – month: 01 year: 1997 text: 1997-01-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo |
PublicationTitle | MICROBIOLOGY and IMMUNOLOGY |
PublicationTitleAlternate | Microbiology and Immunology |
PublicationTitle_FL | Japanese Journal of Microbiology |
PublicationYear | 1997 |
Publisher | Blackwell Publishing Ltd Center For Academic Publications Japan Center for Academic Publications Japan |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Center For Academic Publications Japan – name: Center for Academic Publications Japan |
References | Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417. Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754. Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191. Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82. Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated Il-6 levels and production. J. Immunol. 144: 480-484. Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271. Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485. Anand, R., Siegal, F., Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238. Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622. Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291. Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175. Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384. Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143. Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104. Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (***Il-1β, TNF-α, Il-6, Il-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575. Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13. Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388. Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546. Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36. Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339. Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512. Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248. Hober, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333. Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145. Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of Il-2, Il-1 and TNFα and soluble receptor of Il-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386. Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792. Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187. Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662. Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115. Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267. 13) Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191. 1) Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of II-2, II-1 and TNFα and soluble receptor of II-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386. 9) Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82. 17) Holier, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333. 6) Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388. 24) Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417. 22) Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes form human immunodeficiency virus-positive individuals measured by polymerise chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115. 4) Anand, R., Siegal, E, Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238. 23) Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187. 28) Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36. 2) Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546. 26) Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754. 11) Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267. 3) Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485. 20) Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291. 14) Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622. 12) Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145. 8) Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339. 10) Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248. 19) Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271. 5) Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662. 30) Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (II-1β, TNF-α, II-6, II-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575. 25) Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143. 16) Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175. 29) Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104. 7) Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated II-6 levels and production. J. Immunol. 144: 480-484. 18) Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792. 21) Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13. 27) Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384. 15) Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512. 1987; ii 1989; 5 1990; 54 1986; ii 1986; 35 1987; 7 1989; 8 1992; 148 1993; 163 1993; 91 1988; 240 1988; 141 1991; 139 1990; 144 1991; 7 1991; 5 1993; 37 1989; 50 1989; 78 1991; 88 1992; 119 1996; 40 1988; 177 1988; 85 1988; 239 1992; 4 1992; 62 1994; 7 1992; 5 e_1_2_2_4_1 e_1_2_2_25_1 e_1_2_2_5_1 e_1_2_2_24_1 e_1_2_2_6_1 e_1_2_2_7_1 e_1_2_2_22_1 e_1_2_2_21_1 Wright S.C. (e_1_2_2_30_1) 1988; 141 e_1_2_2_20_1 e_1_2_2_2_1 Heumann D. (e_1_2_2_16_1) 1992; 148 Desch C.E. (e_1_2_2_13_1) 1989; 8 e_1_2_2_29_1 e_1_2_2_28_1 e_1_2_2_27_1 e_1_2_2_26_1 (e_1_2_2_9_1) 1986; 35 e_1_2_2_14_1 Breen E.C. (e_1_2_2_8_1) 1990; 144 e_1_2_2_12_1 e_1_2_2_11_1 e_1_2_2_10_1 Allen J.N. (e_1_2_2_3_1) 1992; 119 e_1_2_2_31_1 e_1_2_2_19_1 Hober D. (e_1_2_2_18_1) 1989; 78 e_1_2_2_17_1 e_1_2_2_15_1 Lathey J.L. (e_1_2_2_23_1) 1994; 7 |
References_xml | – reference: Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of Il-2, Il-1 and TNFα and soluble receptor of Il-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386. – reference: Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622. – reference: Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82. – reference: Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339. – reference: Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792. – reference: Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248. – reference: Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104. – reference: Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175. – reference: Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13. – reference: Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191. – reference: Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384. – reference: Anand, R., Siegal, F., Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238. – reference: Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662. – reference: Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187. – reference: Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36. – reference: Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143. – reference: Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546. – reference: Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417. – reference: Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271. – reference: Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754. – reference: Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145. – reference: Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388. – reference: Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291. – reference: Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485. – reference: Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated Il-6 levels and production. J. Immunol. 144: 480-484. – reference: Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (***Il-1β, TNF-α, Il-6, Il-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575. – reference: Hober, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333. – reference: Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512. – reference: Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115. – reference: Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267. – reference: 18) Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792. – reference: 6) Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388. – reference: 14) Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622. – reference: 27) Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384. – reference: 30) Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (II-1β, TNF-α, II-6, II-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575. – reference: 15) Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512. – reference: 17) Holier, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333. – reference: 20) Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291. – reference: 1) Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of II-2, II-1 and TNFα and soluble receptor of II-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386. – reference: 25) Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143. – reference: 10) Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248. – reference: 5) Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662. – reference: 11) Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267. – reference: 4) Anand, R., Siegal, E, Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238. – reference: 2) Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546. – reference: 21) Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13. – reference: 13) Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191. – reference: 24) Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417. – reference: 19) Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271. – reference: 26) Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754. – reference: 9) Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82. – reference: 28) Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36. – reference: 7) Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated II-6 levels and production. J. Immunol. 144: 480-484. – reference: 3) Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485. – reference: 29) Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104. – reference: 8) Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339. – reference: 12) Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145. – reference: 16) Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175. – reference: 23) Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187. – reference: 22) Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes form human immunodeficiency virus-positive individuals measured by polymerise chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115. – volume: 85 start-page: 289 year: 1988 end-page: 291 article-title: Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome publication-title: Am. J. Med. – volume: 50 start-page: 374 year: 1989 end-page: 384 article-title: Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL‐1 publication-title: Clin. Immunol. Immunopathol. – volume: 4 start-page: 239 year: 1992 end-page: 248 article-title: Direct stimulation of cytokines (IL‐1 beta, TNF‐alpha, IL‐6, IFN‐gamma and GM‐CSF) in whole blood: I. Comparison with isolated PBMC stimulation publication-title: Cytokine – volume: 144 start-page: 480 year: 1990 end-page: 484 article-title: Infection with HIV is associated with elevated Il‐6 levels and production publication-title: J. Immunol. – volume: 7 start-page: 481 year: 1987 end-page: 485 article-title: Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS‐related complex publication-title: J. Clin. Immunol. – volume: 141 start-page: 99 year: 1988 end-page: 104 article-title: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients publication-title: J. Immunol. – volume: 40 start-page: 381 year: 1996 end-page: 388 article-title: A microassay for determination of the cytopathogenicity of human immunodeficiency virus type‐1 isolates publication-title: Microbiol. Immunol. – volume: 37 start-page: 785 year: 1993 end-page: 792 article-title: Granulocyte‐macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection publication-title: Microbiol. Immunol. – volume: 5 start-page: 1405 year: 1991 end-page: 1417 article-title: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? publication-title: AIDS – volume: 78 start-page: 329 year: 1989 end-page: 333 article-title: Production of tumor necrosis factor (TNFα) and interleukin‐1 (IL‐1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity publication-title: Clin. Exp. Immunol. – volume: 119 start-page: 538 year: 1992 end-page: 546 article-title: Human whole blood interleukin‐1‐β production: kinetics, cell source and comparison with TNFα publication-title: J. Lab. Clin. Med. – volume: 54 start-page: 1 year: 1990 end-page: 13 article-title: A selective defect in tissue factor mRNA expression in monocytes from AIDS patients publication-title: Clin. Immunol. Immunopathol. – volume: 4 start-page: 568 year: 1992 end-page: 575 article-title: Direct stimulation of cytokines (***Il‐1β, TNF‐α, Il‐6, Il‐2, IFNγ, and GM‐CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis publication-title: Cytokine – volume: 240 start-page: 80 year: 1988 end-page: 82 article-title: Biological features of HIV‐1 that correlate with virulence in the host publication-title: Science – volume: 239 start-page: 617 year: 1988 end-page: 622 article-title: The human immunodeficiency virus: infectivity and mechanisms of pathogenesis publication-title: Science – volume: 8 start-page: 141 year: 1989 end-page: 145 article-title: Production of human tumor necrosis factor from whole blood ex vivo publication-title: Lymphokine Res. – volume: 62 start-page: 168 year: 1992 end-page: 175 article-title: TNFα production by U937 promonocytes is enhanced by factors released from HIV‐infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV‐infected T4 cells publication-title: Clin. Immunol. Immunopathol. – volume: 91 start-page: 30 year: 1993 end-page: 36 article-title: Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV‐1‐infected patients publication-title: Clin. Exp. Immunol. – volume: 139 start-page: 191 year: 1991 article-title: Evaluation of a test system for measuring cytokine production in human whole blood cell cultures publication-title: J. Immunol. Methods – volume: ii start-page: 234 year: 1987 end-page: 238 article-title: Non‐cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders publication-title: Lancet – volume: 7 start-page: 381 year: 1991 end-page: 386 article-title: Serum levels of Il‐2, Il‐1 and TNFα and soluble receptor of Il‐2 in HIV‐1 infected patients publication-title: AIDS Res. Hum. Retroviruses – volume: 88 start-page: 1747 year: 1991 end-page: 1754 article-title: Dysregulation of in vitro cytokine production by monocytes during sepsis publication-title: J. Clin. Invest. – volume: 5 start-page: 1266 year: 1992 end-page: 1271 article-title: Tumor necrosis factor‐α in advanced HIV in the absence of AIDS‐related secondary infections publication-title: J. Acq. Immun. Defic. Syndr. – volume: 5 start-page: 139 year: 1989 end-page: 143 article-title: Enhancement of HIV replication and giant cell formation by tumor necrosis factor publication-title: AIDS Res. Hum. Retroviruses – volume: 7 start-page: 109 year: 1994 end-page: 115 article-title: Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus‐positive individuals measured by polymerase chain reaction publication-title: J. Acq. Immun. Defic. Syndr. – volume: 35 start-page: 334 year: 1986 end-page: 339 article-title: Classification system for human T‐lymphotropic virus type III/lymphadenopathy‐associated virus infection publication-title: MMWR – volume: 148 start-page: 3505 year: 1992 end-page: 3512 article-title: Control of lipopolysaccharide (LPS) binding and LPS‐induced tumor necrosis factor secretion in human peripheral blood monocytes publication-title: J. Immunol. – volume: ii start-page: 660 year: 1986 end-page: 662 article-title: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections publication-title: Lancet – volume: 163 start-page: 259 year: 1993 end-page: 267 article-title: Novel method for the measurement of cytokine production by a one‐stage procedure publication-title: J. Immunol. Methods – volume: 177 start-page: 181 year: 1988 end-page: 187 article-title: Enhancement of human immunodeficiency virus production of natural lymphotoxin publication-title: Med. Microbiol. Immunol. – volume: 148 start-page: 3505 year: 1992 ident: e_1_2_2_16_1 article-title: Control of lipopolysaccharide (LPS) binding and LPS‐induced tumor necrosis factor secretion in human peripheral blood monocytes publication-title: J. Immunol. doi: 10.4049/jimmunol.148.11.3505 – ident: e_1_2_2_27_1 doi: 10.1172/JCI115493 – ident: e_1_2_2_7_1 doi: 10.1111/j.1348-0421.1996.tb01083.x – ident: e_1_2_2_4_1 doi: 10.1007/BF00915059 – ident: e_1_2_2_24_1 doi: 10.1007/BF00211217 – ident: e_1_2_2_17_1 doi: 10.1016/0090-1229(92)90069-Z – ident: e_1_2_2_10_1 doi: 10.1126/science.2832945 – ident: e_1_2_2_19_1 doi: 10.1111/j.1348-0421.1993.tb01706.x – ident: e_1_2_2_21_1 doi: 10.1016/0002-9343(88)90576-1 – ident: e_1_2_2_6_1 doi: 10.1016/S0140-6736(86)90169-8 – volume: 144 start-page: 480 year: 1990 ident: e_1_2_2_8_1 article-title: Infection with HIV is associated with elevated Il‐6 levels and production publication-title: J. Immunol. doi: 10.4049/jimmunol.144.2.480 – ident: e_1_2_2_15_1 doi: 10.1126/science.3277274 – ident: e_1_2_2_11_1 doi: 10.1016/1043-4666(92)90062-V – ident: e_1_2_2_31_1 doi: 10.1016/1043-4666(92)90021-I – ident: e_1_2_2_12_1 doi: 10.1016/0022-1759(93)90130-Y – ident: e_1_2_2_25_1 doi: 10.1097/00002030-199112000-00001 – volume: 35 start-page: 334 year: 1986 ident: e_1_2_2_9_1 article-title: Classification system for human T‐lymphotropic virus type III/lymphadenopathy‐associated virus infection publication-title: MMWR – ident: e_1_2_2_22_1 doi: 10.1016/0090-1229(90)90001-7 – ident: e_1_2_2_28_1 doi: 10.1016/0090-1229(89)90144-X – volume: 78 start-page: 329 year: 1989 ident: e_1_2_2_18_1 article-title: Production of tumor necrosis factor (TNFα) and interleukin‐1 (IL‐1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity publication-title: Clin. Exp. Immunol. – ident: e_1_2_2_29_1 doi: 10.1111/j.1365-2249.1993.tb03349.x – ident: e_1_2_2_14_1 doi: 10.1016/0022-1759(91)90188-L – volume: 7 start-page: 109 year: 1994 ident: e_1_2_2_23_1 article-title: Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus‐positive individuals measured by polymerase chain reaction publication-title: J. Acq. Immun. Defic. Syndr. – volume: 8 start-page: 141 year: 1989 ident: e_1_2_2_13_1 article-title: Production of human tumor necrosis factor from whole blood ex vivo publication-title: Lymphokine Res. – volume: 141 start-page: 99 year: 1988 ident: e_1_2_2_30_1 article-title: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients publication-title: J. Immunol. doi: 10.4049/jimmunol.141.1.99 – ident: e_1_2_2_5_1 doi: 10.1016/S0140-6736(87)90826-9 – ident: e_1_2_2_26_1 doi: 10.1089/aid.1989.5.139 – ident: e_1_2_2_2_1 doi: 10.1089/aid.1991.7.381 – ident: e_1_2_2_20_1 doi: 10.1097/00126334-199212000-00010 – volume: 119 start-page: 538 year: 1992 ident: e_1_2_2_3_1 article-title: Human whole blood interleukin‐1‐β production: kinetics, cell source and comparison with TNFα publication-title: J. Lab. Clin. Med. |
SSID | ssj0027284 |
Score | 1.4919283 |
Snippet | Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using... Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using... Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using... Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNF alpha and IL-6 production... |
SourceID | proquest pascalfrancis crossref wiley nii jstage istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 939 |
SubjectTerms | Biological and medical sciences Fundamental and applied biological sciences. Psychology HIV-1 Human viral diseases IL-6 Infectious diseases Medical sciences Microbiology P4 cells Patients Phenotype Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains TNFα Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virology Whole blood |
Title | Production of TNFα and IL-6 by Activated Whole Blood from HIV-1 Infected Patients Detected by a One-Stage Procedure: Relationship with the Phenotype of HIV-1 Isolates |
URI | https://api.istex.fr/ark:/67375/WNG-B89DTZ5D-K/fulltext.pdf https://www.jstage.jst.go.jp/article/mandi1977/41/12/41_12_939/_article/-char/en https://cir.nii.ac.jp/crid/1570009753174902912 https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1348-0421.1997.tb01953.x https://www.proquest.com/docview/16371818 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | MICROBIOLOGY and IMMUNOLOGY, 1997, Vol.41(12), pp.939-946 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKLkhcEE9RYMEHxKUKWufpcIKlW1q2LRxaWHGxEseBLpCiPoDya7jzJ5mxnTRBrNjlYqVO7KSZz_bMZL4xIQ-jIEgjmacOLAc5GChMwpCKQyd3E9BOYy_hGTr0R-OwP_VfHgfHrdbPWtTSepU-lj_-yiv5H6lCHcgVWbLnkGzVKVTAMcgXSpAwlGeS8WuTrtXqfJNxr6OpsybGd-iEqFsiceFrgnrlN9wK10SqG1ZJf_DGYTYcC87bFKvLTqZWpgabd-aFckCFfI-MKljssvVCNaLoMNrLeHORdPVBFXPt1sUPBKZ_eAeo0NbV4NHsz_xPSFNpePgPVLGZA-7yhn-2j4HgzUBlSy8ZrivsniSG6NbbujRMOtjKpWGpXDxwUBWrT9M-q8PRrU26sUmHZNfv2Lg0T18aPJ87MFUxJGpG6BnHL4ll0Gg9H_f4lehNh0MxOTyeXCC7LhgiOPV3B0dbk97lJkGZfWCb1tbGip1yp4YKtIujGaounmhRgopTzGYYoZssYZDmZneVhvlTN6K0FjS5Sq5Y84U-M1i8RlqquE4umQ1NNzfIry0i6TyngEiqEUlBxhQRSdMNrRBJNSKpRiRFRFKNGFoikpaIpCUidXNaIZJWiHxC63ikiEcKeKQVHvFxbO8WjzfJtHc4ed537HYgjgSt1gNdisd-GiRZkHohaLE8U4nrZmHoxzLzpYTFh3lK8VS68JMzlWdKhXEeZFyBYcO9W2SngCe8TWiSh3kaxgmTievzTKaBJyVjWRC5uUzDtE3iUkJC2lz5uGXLJ1GzmUG6AqUrULrCSld8bxOvavvFZIw5U6tHGghVk2TxEWMuo0C8Hb8QBzzuTt4FXXHUJk8NUmpXapGLz8iDY2DPCR96d20Jg6O6AomcMG-2yR5gDP4Ylgw3uNhHej2L_HjfjZkL5xvoq-6E7iCY3NvkQYlGAYsRfmFMCjVfLwUYd6DrMg7vT4P0HC9AjAYjfXjnn73fJZe3s8Y9srNarNUemAar9L4enb8BCA0JEA |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Production+of+TNF+alpha+and+IL-6+by+activated+whole+blood+from+HIV-1+infected+patients+detected+by+a+one-stage+procedure%3A+Relationship+with+the+phenotype+of+HIV-1+isolates&rft.jtitle=Microbiology+and+immunology&rft.au=Benyoucef%2C+S&rft.au=Hober%2C+D&rft.au=Shen%2C+Lu&rft.au=Ajana%2C+F&rft.date=1997-01-01&rft.issn=0385-5600&rft.volume=41&rft.issue=12&rft.spage=939&rft.epage=946&rft_id=info:doi/10.1111%2Fj.1348-0421.1997.tb01953.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-5600&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-5600&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-5600&client=summon |